Skip to main content
CONTEC MEDICAL SYSTEMS CO., LTD. logo

CONTEC MEDICAL SYSTEMS CO., LTD. — Investor Relations & Filings

Ticker · 300869 ISIN · CNE1000047F0 LEI · 6556007SL3V6YKCWVA55 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 789 across all filing types
Latest filing 2021-03-11 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 300869

About CONTEC MEDICAL SYSTEMS CO., LTD.

https://www.contecmed.com.cn

CONTEC Medical Systems Co., Ltd. focuses on the research, development, manufacturing, and distribution of medical electronic instruments. The product portfolio encompasses a wide range of diagnostic and monitoring solutions, including pulse oximeters, blood pressure monitors, electrocardiographs, ultrasound equipment, and multi-parameter patient monitors. Additionally, the company provides specialized devices such as fetal monitors, sleep apnea screening systems, and biochemical analyzers. By leveraging integrated research and large-scale production facilities, the organization delivers medical technology designed for clinical, hospital, and home healthcare environments. The company emphasizes technical innovation and adheres to international quality standards to ensure the precision and reliability of its medical hardware and software solutions.

Recent filings

Filing Released Lang Actions
关于医疗器械注册证变更的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement (655 characters) about a change in a medical device registration certificate issued by a regulatory authority (Hebei Provincial Drug Administration). It details the product name, registration number, approval date, and changes made. The document includes a risk warning and states the impact on the company. There is no financial data, no mention of financial results, no detailed report or presentation, and no indication of a meeting or voting results. It is a regulatory announcement about a product registration change, which does not fit into financial report categories like Annual Report, Interim Report, or Earnings Release. It is not a report publication announcement since it contains substantive information about the registration change itself. The best fitting category is Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2021-03-11 Chinese
关于投资设立子公司的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the company's investment to establish a wholly-owned subsidiary. It includes details about the investment, board approval, and the purpose and risks of the investment. There is no financial data or report content, but rather a corporate action announcement. This fits the category of Capital/Financing Update (CAP), as it relates to company fundraising or capital structure changes through investment in a subsidiary. The document length is short and it is not a report publication or certification, so it is not RPA or RNS.
2021-03-05 Chinese
信息披露暂缓与豁免管理制度
Governance Information Classification · 95% confidence The document is titled 'Information Disclosure Delay and Exemption Management System' for 康泰医学系统（秦皇岛）股份有限公司, dated March 2021. It outlines internal policies and procedures related to the management of information disclosure delays and exemptions, referencing relevant laws and stock exchange rules. The content is a governance or compliance policy document rather than a financial report, earnings release, or announcement. It does not contain financial data, earnings, voting results, or management changes. It is a detailed internal governance document about disclosure practices, fitting best under Governance Information (CGR). The document length is 3228 characters, which is relatively short but contains substantive policy content, not just an announcement or certification. Therefore, the classification is CGR with high confidence.
2021-03-05 Chinese
金融衍生品交易业务管理制度
Governance Information Classification · 95% confidence The document is a detailed internal policy titled '金融衍生品交易业务管理制度' (Financial Derivatives Trading Business Management System) issued by 康泰医学系统（秦皇岛）股份有限公司. It outlines the company's rules, management principles, approval authorities, operational procedures, risk control measures, and responsibilities related to financial derivatives trading. There is no indication that this is a financial report, earnings release, or regulatory filing announcement. It is not a certification or a brief announcement but a comprehensive internal governance document. The content focuses on internal control, risk management, and operational guidelines, which aligns with governance information about company practices and internal rules. Therefore, the most appropriate classification is Governance Information (CGR). The document length is under 5,000 characters, but it is a full policy document, not a mere announcement or notice, so it is not RPA or RNS.
2021-03-05 Chinese
第三届董事会第六次会议决议公告
Board/Management Information Classification · 95% confidence The document is titled as a resolution announcement from the third board of directors' sixth meeting of Kangtai Medical System (Qinhuangdao) Co., Ltd. It details the convening of the board meeting, the agenda items discussed, and the voting results on various proposals. The content focuses on board decisions and approvals, such as investment in a subsidiary and the establishment of management systems. There is no financial data, earnings information, or regulatory filings beyond board meeting resolutions. This fits the category of Board/Management Information (MANG), which covers announcements of changes or decisions by the company's board of directors or senior management.
2021-03-05 Chinese
申万宏源证券承销保荐有限责任公司关于康泰医学系统（秦皇岛）股份有限公司首次公开发行网下配售限售股上市流通的核查意见
Audit Report / Information Classification · 95% confidence The document is a detailed verification opinion from a securities underwriting and sponsorship company regarding the listing and circulation of restricted shares from an initial public offering (IPO) of a company named 康泰医学系统（秦皇岛）股份有限公司. It references regulatory approvals, share issuance details, lock-up periods, and compliance with relevant securities laws and stock exchange rules. The document includes detailed tables of shareholders and share quantities related to the lifting of restrictions on shares. This type of document is a formal verification or audit opinion related to share issuance and listing compliance, not a financial report, earnings release, or management discussion. It is not an announcement of voting results, nor a proxy statement or remuneration report. It is a specialized audit or verification report related to IPO share lock-up release and listing compliance. Therefore, the most appropriate classification is Audit Report / Information (AR). The document length is substantial (15,000 characters), and it contains detailed substantive content, not just an announcement or certification, so it is not RPA or RNS. Q1 2021
2021-02-19 Chinese

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.